deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT01586312

Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells (MSV_allo)

Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells (MSV*) *MSV: Mesenchymal Stromal Cells From Valladolid

Sponsor: Centro Medico Teknon

Conditions Arthritis of Knee Knee Osteoarthritis Osteoarthritis, Knee
Interventions Allogenic mesenchymal stromal cells injection Hyaluronic Acid
Updated 8 times since 2017 Last updated: Sep 26, 2015 Started: Apr 30, 2012 Primary completion: Dec 31, 2013 Completion: Jun 30, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01586312, this PHASE1/PHASE2 trial focuses on Arthritis of Knee and Knee Osteoarthritis and remains completed. Sponsored by Centro Medico Teknon, it has been updated 8 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Sep 2020 · 27 months · monthly snapshotCompleted~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE1_PHASE2

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE1_PHASE2

▶ Show 3 earlier versions

  1. Sep 2020 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

  2. Jun 2018 — Sep 2020 [monthly]

    Completed PHASE1_PHASE2

  3. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1_PHASE2

    First recorded

Apr 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centro Medico Teknon
  • Red de Terapia Celular
  • Sanidad de Castilla y León
  • University of Valladolid
Data source: Red de Terapia Celular

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations